Skin Diseases  >>  Berinert (C1 esterase inhibitor (human) IV)  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Berinert (C1 esterase inhibitor (human) IV) / CSL Behring
NCT01108848: Patient Registry Study of Berinert® in Normal Clinical Practice

Completed
N/A
318
US, Europe
Berinert® (C1 Esterase Inhibitor), C1-INH, Berinert P, CE1145
CSL Behring, Chiltern International Inc.
Includes: Hereditary Angioedema
04/14
04/14

Download Options